Low Dose Naltrexone
I have been seeing Dr. Rubin for about two years and I can't begin to tell you the difference that he has made. I was…read more→
I was experiencing severe right sciatic pain, and a severe vice-like stabbing in my right calf, from multiple lumber herniated discs putting pressure on my…read more→
Dr Rubin has given me a new lease on life. He is patient, kind, and very understanding and he is a very good listener. But…read more→
I have been a patient of Dr. Rubin for the last two years. He is both an extremely competent pain management professional and a doctor…read more→
Chronic Pain due to an autoimmune condition or fibromyalgia?
Low Dose Naltrexone (LDN) may be your answer.
Low-dose Naltrexone (LDN) is an off-label use of the FDA-approved drug Naltrexone. Rather than the traditional 50mg daily dose of Naltrexone for those addicted to narcotics or alcohol, LDN is used at doses no higher than 4.5mg (not lower than 1.5mg) and is generally taken at bedtime.
Naltrexone is an opiate blocking drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment.
It may initially seem strange that a drug that blocks the effects of pain medication can have an opposite effect when given at a low dosage. However, there is a strong precedent for this concept.
When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to have an anti inflammatory properties in the treatment of chronic pain.
Additionally, there is some evidence of improvement in Crohn’s disease, multiple sclerosis, and neurodegenerative conditions such as Parkinson’s disease and amyotrophic lateral sclerosis (ALS).
Low Dose Naltrexone (LDN) typically delivers a variety of benefits to patients.
Decreased generalized pain
Enhanced immune function
Decreased antibody production
Fights various autoimmune disease symptoms
Getting started is easy, just call us today for a personalized evaluation.
According to the Federal Government’s National Institutes of Health (NIH):
“Low-dose naltrexone (LDN) has been demonstrated to reduce symptom severity in conditions such as fibromyalgia, Crohn’s disease, multiple sclerosis, and complex regional pain syndrome. These effects may be unique to low dosages of naltrexone and appear to be entirely independent from naltrexone’s better-known activity on opioid receptors.”
Read the full NIH report here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962576/
Additionally, watch the following video for a more succinct description of LDN and how it works.